首页
>
>
投稿咨询
微信添加科研助理

了解相关问题

加急服务
微信添加科研助理

了解相关问题

Drug Testing and Analysis
ISSN：1942-7603

Drug Testing and Analysis

DRUG TEST ANAL
学科领域：医学
是否预警：不在预警名单内
是否OA：否
录用周期：约3.0个月
新锐分区：医学3区
年发文量：176
影响因子：2.7
JCR分区：Q2

基本信息

随着毒品在21世纪生活中发病率的上升，其检测和分析变得越来越重要。体育、工作场所、犯罪调查、国土安全、制药业和环境只是其中一些引人注目的领域，在这些领域中，分析测试为发现外来物质的存在提供了重要的调查工具。除了通常的主要研究文章、案例报告和信件的出版费用外，药物测试和分析还提供了以下方面的独特组合：“如何"材料，如”教程“和”评论“，推测性文章（“评论”和“观点”，为分析测试的各个方面提供了更广泛的科学和社会背景），“年度禁用物质审查”（对已确立和新宣布为非法的化合物的表征所用的方法进行严格评价）。药物测试和分析采用了独特的多学科方法来确定有争议的化合物。讨论色谱法、质谱法、免疫学方法、一维/二维凝胶电泳等方法的论文，只要其应用与下列六个关键主题中的任何一个相关，都是受欢迎的。
1942-7603SCIE/Scopus收录
2.7
点击查看最新影响趋势>
2.5
新
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
3区
CHEMISTRY, ANALYTICAL 分析化学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
N/A
新
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科：BIOCHEMICAL RESEARCH METHODS
SCIE
Q2
41/86
学科：CHEMISTRY, ANALYTICAL
SCIE
Q3
56/111
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
164/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科：BIOCHEMICAL RESEARCH METHODS
SCIE
Q2
35/86
学科：CHEMISTRY, ANALYTICAL
SCIE
Q2
38/111
学科：PHARMACOLOGY & PHARMACY
SCIE
Q2
136/353
44
176
点击查看年发文量趋势图>
5%约75%约3.0个月-BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL
25.9%
点击查看自引率趋势图>
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
94.32%36.13%-
CiteScore：6.20
SJR：0.623
SNIP：1.085
学科类别分区排名百分位
大类：Chemistry
小类：Spectroscopy
Q2
23 / 79
大类：Chemistry
小类：Pharmaceutical Science
Q2
54 / 185
大类：Chemistry
小类：Analytical Chemistry
Q2
53 / 160
大类：Chemistry
小类：Environmental Chemistry
Q2
61 / 150

期刊高被引文献

Application of an activity-based receptor bioassay to investigate the in vitro activity of selected indole- and indazole-3-carboxamide-based synthetic cannabinoids at CB1 and CB2 receptors.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2517
Metabolic profiling of synthetic cannabinoid 5F-ADB by human liver microsome incubations and urine samples using high-resolution mass spectrometry.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2566
Synthesis and pharmacology of new psychoactive substance 5F-CUMYL-P7AICA, a scaffold- hopping analog of synthetic cannabinoid receptor agonists 5F-CUMYL-PICA and 5F-CUMYL-PINACA.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2491
Sulfate metabolites improve retrospectivity after oral testosterone administration.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2529
Microfluidic electrochemical immunosensor for the trace analysis of cocaine in water and body fluids.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2515
Monitoring of direct alcohol markers in alcohol use disorder patients during withdrawal treatment and successive rehabilitation.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2567
Analytical quantification, intoxication case series, and pharmacological mechanism of action for N-ethylnorpentylone (N-ethylpentylone or ephylone).
来源期刊：Drug testing and analysisDOI：10.1002/dta.2502
Quantification of cocaine and cocaine metabolites in dried blood spots from a controlled administration study using liquid chromatography-tandem mass spectrometry.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2537
5F-MDMB-PICA Metabolite Identification and Cannabinoid Receptor Activity.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2688
Stability of mephedrone and five of its phase I metabolites in human whole blood.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2525
Development of a mono-specific anti-VEGF bivalent nanobody with extended plasma half-life for treatment of pathologic neovascularization.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2693
A fatal chemsex case involving γ-butyrolactone and 4-methylethcathinone.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2677
Decarbonylation: A metabolic pathway of cannabidiol in humans.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2572
Chemical profiling of the synthetic cannabinoid MDMB-CHMICA: Identification, assessment, and stability study of synthesis-related impurities in seized and synthesized samples.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2652
Oxytocin analysis from human serum, urine, and saliva by orbitrap liquid chromatography-mass spectrometry.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2475
Retrospective analysis for valproate screening targets with liquid chromatography-high resolution mass spectrometry with positive electrospray ionization: An omics-based approach.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2543
A systematic investigation of forensic hair decontamination procedures and their limitations.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2681
LC-MS/MS Screening Method Using Information-Dependent Acquisition of Enhanced Product Ion Mass Spectra for Synthetic Cannabinoids Including Metabolites in Urine.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2664
Hair analysis to discriminate voluntary doping vs inadvertent ingestion of the aromatase inhibitor letrozole.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2555
Gas chromatography-mass spectrometry analysis of non-hydrolyzed sulfated steroids by degradation product formation.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2606
Interactions of phenethylamine-derived psychoactive substances of the 2C-series with human monoamine oxidases.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2494
Elimination profile of triamcinolone hexacetonide and its metabolites in human urine and plasma after a single intra-articular administration.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2614
Budesonide use and misuse in sports: elimination profiles of budesonide and metabolites after intranasal, high-dose inhaled and oral administrations.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2678
Meldonium long-term excretion period and pharmacokinetics in blood and urine of healthy athlete volunteers.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2521
Evidence of seasonal variation of ethyl glucuronide in hair: Modeling a seven-year data series.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2470
1 H-15 N HMBC NMR as a tool for rapid identification of isomeric azaindoles: The case of 5F-MDMB-P7AICA.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2573
Detection of the myostatin-neutralizing antibody Domagrozumab in serum by means of Western blotting and LC-HRMS.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2729
Determination of DP-VPA and its active metabolite, VPA, in human plasma, urine, and feces by UPLC-MS/MS: A clinical pharmacokinetics and excretion study.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2579
A comprehensive approach to detecting multitudinous bioactive peptides in equine plasma and urine using HILIC coupled to high resolution mass spectrometry.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2671
Solid-phase extraction-liquid chromatography-tandem mass spectrometry method for the qualitative analysis of 61 synthetic cannabinoid metabolites in urine.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2680
7-keto-DHEA metabolism in humans. Pitfalls in interpreting the analytical results in the antidoping field.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2734
Development of an ultra-high performance liquid chromatography-tandem mass spectrometry method for the determination of anabolic steroids currently available on the black market in the Czech Republic and Slovakia.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2541
The use of hair as a long-term indicator of low-dose β2 agonist treatments in cattle: Implications for growth-promoting purposes monitoring.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2551
Detectability of various cannabinoids in plasma samples of cannabis users: Indicators of recent cannabis use?
来源期刊：Drug testing and analysisDOI：10.1002/dta.2682
In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2611
Ionized magnesium and calcium concentration and their ratio in equine plasma samples as determined by a regulatory laboratory compared to a clinical reference laboratory.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2509
Isotopically labeled boldenone as a better marker of derivatization efficiency for improved quality control in anti-doping analysis.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2556
Creatinine excretion in consecutive urine samples after controlled ingestion of water.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2514
The occurrence of putative cognitive enhancing research peptides in seized pharmaceutical preparations: an incentive for controlling agencies to prepare for future encounters of the kind.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2717
Identification of phenobarbital and other barbiturates in forensic drug screening using positive electrospray ionization liquid chromatography-high resolution mass spectrometry.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2603
Isotopomics by isotope ratio monitoring by 13 C Nuclear Magnetic Resonance Spectrometry on cutting agents in heroin: a new approach for illicit drugs trafficking route elucidation.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2745
Optimization and validation of simultaneous analyses of ecgonine, cocaine, and seven metabolites in human urine by gas chromatography-mass spectrometry using a one-step solid-phase extraction.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2547
Analysis of tretoquinol and its metabolites in human urine by liquid chromatography-tandem mass spectrometry.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2714
Detection of ESAs in equine urine and blood by SAR-PAGE.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2569
Urinary concentrations of AICAR and mannitol in athlete population.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2557
Detection and characterization of the new synthetic cannabinoid APP-BINACA in forensic casework.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2698
Evaluation of an on-site test device for the heroin metabolite 6-acetylmorphine in urine.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2559
An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2554
Metabolism of vesatolimod in rat, dog, and human liver microsomes: Metabolic stability assessment, metabolite identification, and interspecies comparison.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2483
Administration study of recombinant human relaxin-2 in horse for doping control purpose.
来源期刊：Drug testing and analysisDOI：10.1002/dta.2732

相关文章

Materials Today Bio解析：IF=8.7，8天初审
2025-11-25
《ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE》德国老牌产科期刊免版面费、非预警，毕业保底首选！
2025-11-25
Journal of Multidisciplinary Healthcare：IF= 2.4，中科院3区，JCR Q2，多学科综合医学开放获取期刊，应用性强，审稿迅速，编辑反馈专业！
2025-10-15
European Journal of Medical Genetics：IF= 1.7，中科院4区，JCR Q3，医学遗传学期刊，涵盖分子遗传学、临床基因诊断与罕见病研究，欧洲地区影响力较稳，国际传播适中！
2025-10-15
ANNALS OF ONCOLOGY：中科院1区，肿瘤学，接受率为25%
2025-10-15
Journal of Cystic Fibrosis：权威官方背景，高影响力，整体周期约 3 个月，部分 1 天录用
2025-10-15
JOURNAL OF INHERITED METABOLIC DISEASE：影响因子平稳，学术认可度高，年发文稳定，4个月录用
2025-10-15
JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE：自引风险小，审稿周期短，发表难度低，但if持续下降
2025-10-15
Neurobiology of Stress：中科院 2 区，认可度高，国人发文第二，机会公平
2025-10-15
NATURE REVIEWS DRUG DISCOVERY：中科院1区，生物工程与应用微生物，药学，接受率为21%
2025-10-15

期刊推荐

AAPS Journal封面

AAPS Journal

学科领域：医学
影响因子：3.7
中科院分区： 3区
AAPS PHARMSCITECH封面

AAPS PHARMSCITECH

学科领域：医学
影响因子：4
中科院分区： 3区
Academic Pediatrics封面

Academic Pediatrics

学科领域：医学
影响因子：2.8
中科院分区： 3区
ACTA ANAESTHESIOLOGICA SCANDINAVICA封面

ACTA ANAESTHESIOLOGICA SCANDINAVICA

学科领域：医学
影响因子：2
中科院分区： 3区
论文发表 2-4个月录用 7500+文章录用 不成功可退款
新
2026年3月发布（新锐分区）
大类学科小类学科Top期刊综述期刊
医学3区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
3区
CHEMISTRY, ANALYTICAL 分析化学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学3区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
3区
CHEMISTRY, ANALYTICAL 分析化学
3区
PHARMACOLOGY & PHARMACY 药学
3区
否
否
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学3区
BIOCHEMICAL RESEARCH METHODS 生化研究方法
2区
CHEMISTRY, ANALYTICAL 分析化学
2区
PHARMACOLOGY & PHARMACY 药学
3区
否
否